# Neos Therapeutics, Inc.: Form D filings

Neos Therapeutics, Inc., a pharmaceuticals company in Grand Prairie, TX, filed 11 Form D notices with the SEC between 2009 and 2015. The latest, on February 20, 2015, reports $20.6 million sold of a $20.6 million offering to 27 investors.

Find out what Neos Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Neos%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Neos%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneos-therapeutics-inc-1467652)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Neos%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Neos%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneos-therapeutics-inc-1467652)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2940 N. HIGHWAY 360, SUITE 400, Grand Prairie, TX, 75050
- Phone: (972) 408-1360
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1467652

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 20, 2015 | Amendment | $20,624,355 | $20,624,355 | $0 | 27 | Dec 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765215000003/0001467652-15-000003-index.htm) |
| Jan 7, 2015 | New notice | $15,000,000 | $8,000,000 | $7,000,000 | 10 | Dec 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765215000001/0001467652-15-000001-index.htm) |
| Apr 9, 2014 | New notice | $2,500,000 | $2,500,000 | $0 | 3 | Mar 28, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765214000003/0001467652-14-000003-index.htm) |
| Mar 4, 2014 | Amendment | $15,500,170 | $15,500,170 | $0 | 25 | Dec 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765214000002/0001467652-14-000002-index.htm) |
| Jan 2, 2014 | New notice | $15,000,000 | $8,067,240 | $6,932,760 | 12 | Dec 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765214000001/0001467652-14-000001-index.htm) |
| Jul 16, 2012 | New notice | $30,000,000 | $18,267,890 | $11,732,110 | 41 | Jul 2, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765212000001/0001467652-12-000001-index.htm) |
| Jun 9, 2011 | New notice | $20,000,000 | $13,554,505 | $6,445,495 | 48 | May 27, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765211000001/0001467652-11-000001-index.htm) |
| Nov 23, 2009 | Amendment | $50,000,000 | $24,195,000 | $25,805,000 | 57 | Jun 19, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765209000006/0001467652-09-000006-index.htm) |
| Oct 7, 2009 | Amendment | $40,000,000 | $19,195,000 | $20,805,000 | 56 | Jun 19, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765209000005/0001467652-09-000005-index.htm) |
| Oct 7, 2009 | Amendment | $40,000,000 | $19,145,000 | $20,855,000 | 55 | Jun 19, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765209000004/0001467652-09-000004-index.htm) |
| Jul 2, 2009 | New notice | $40,000,000 | $14,570,000 | $25,430,000 | 42 | Jun 19, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1467652/000146765209000002/0001467652-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Steven Lutz | Executive Officer |  |
| Carolyn Sikes | Executive Officer |  |
| Arlen Ewart | Executive Officer |  |
| Russ McMahen | Executive Officer |  |
| Stacie Switzer | Executive Officer |  |
| Margaret Cabano | Executive Officer |  |
| Greg Robitaille | Director |  |
| Richard Eisenstadt | Executive Officer |  |
| Alan Heller | Director |  |
| Asif Mughal | Executive Officer |  |
| Mark Tengler | Executive Officer |  |
| Ralph Iannelli | Director |  |
| Vipin Garg | Executive Officer, Director |  |
| Bryant Fong | Director |  |
| Edward Schnipper | Director |  |
| Dorothy Engelking | Executive Officer |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of Feb 16, 2015](https://specstream.ai/data/form-d/week/2015-02-16) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Neos Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).